QDEL - Quidel more quick diagnosis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QDEL - Quidel more quick diagnosis

QDEL 27.35

-0.5%

Nov 28 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike Relyea who wrote (308)	1/10/1997 8:45:00 AM
From: Robert Busse	of 1693

Mike check out newspage.com You may recall that Unipath is the company featured in the WSJ a few months ago w/ the product that will compete w/ QDEL's Safeplan, their innovative contraception method. Looks like Unipath is trying to consolidate its Clearr blue easy pregnancy test w/ its Uniplan test (when approved) so they can be marketed together-a good strategy, I think. I still believe the QDEL Safeplan test- when approved) will be less complicated and less expensive than UNIPLAN- anyway, I think the market is big enough for both products. BOB

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next